Eli Lilly & Co. (NYSE:LLY)

CAPS Rating: 4 out of 5

The Company discovers, develops, manufactures and sells products in one of its business segment of pharmaceutical products to prevent and treat human diseases.

Recs

0
Player Avatar birdup (< 20) Submitted: 12/6/2011 7:06:47 PM : Outperform Start Price: $38.33 LLY Score: +2.28

Cramer

Report this Post Reply

Featured Broker Partners


Advertisement